Skip to main content
PMC home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1980 Apr;56(3):285–304.

Paget's disease of bone.

E S Siris, T P Jacobs, R E Canfield
PMCID: PMC1805153  PMID: 6929198

Full text

PDF
285

Images in this article

288Fig. 2a
on p.288
289Fig. 2b
on p.289
291Fig. 3
on p.291

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT F., HENNEMAN P. H. The suppression of Paget's disease with ACTH and cortisone. Trans Assoc Am Physicians. 1955;68:238–246. [PubMed] [Google Scholar]
  2. ASTRE G. Maladie osseuse pagétoide d'un crane gallo-romain. Rev Pathol Gen Physiol Clin. 1957 Jun;57(689):955–961. [PubMed] [Google Scholar]
  3. Altman R. D., Johnston C. C., Khairi M. R., Wellman H., Serafini A. N., Sankey R. R. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med. 1973 Dec 27;289(26):1379–1384. doi: 10.1056/NEJM197312272892601. [DOI] [PubMed] [Google Scholar]
  4. Avramides A., Flores A., DeRose J., Wallach S. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab. 1976 Mar;42(3):459–463. doi: 10.1210/jcem-42-3-459. [DOI] [PubMed] [Google Scholar]
  5. Avramides A. Salmon and porcine calcitonin treatment of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):78–85. [PubMed] [Google Scholar]
  6. BROWN J. H., KENNEDY B. J. MITHRAMYCIN IN THE TREATMENT OF DISSEMINATED TESTICULAR NEOPLASMS. N Engl J Med. 1965 Jan 21;272:111–118. doi: 10.1056/NEJM196501212720301. [DOI] [PubMed] [Google Scholar]
  7. Bilezikian J. P., Canfield R. E., Jacobs T. P., Polay J. S., D'Adamo A. P., Eisman J. A., DeLuca H. F. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. N Engl J Med. 1978 Aug 31;299(9):437–441. doi: 10.1056/NEJM197808312990902. [DOI] [PubMed] [Google Scholar]
  8. Canfield R., Rosner W., Skinner J., McWhorter J., Resnick L., Feldman F., Kammerman S., Ryan K., Kunigonis M., Bohne W. Diphosphonate therapy of paget's disease of bone. J Clin Endocrinol Metab. 1977 Jan;44(1):96–106. doi: 10.1210/jcem-44-1-96. [DOI] [PubMed] [Google Scholar]
  9. Condon J. R., Reith S. B., Nassim J. R., Millard F. J., Hilb A., Stainthorpe E. M. Treatment of Paget's disease of bone with mithramycin. Br Med J. 1971 Feb 20;1(5746):421–423. doi: 10.1136/bmj.1.5746.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cullen P., Russell R. G., Walton R. J., Whiteley J. Frequencies of HLA-A and HLA-B histocompatibility antigens in Paget's disease of bone. Tissue Antigens. 1976 Jan;7(1):55–56. doi: 10.1111/j.1399-0039.1976.tb01030.x. [DOI] [PubMed] [Google Scholar]
  11. DeRose J., Singer F. R., Avramides A., Flores A., Dziadiw R., Baker R. K., Wallach S. Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment. Am J Med. 1974 Jun;56(6):858–866. doi: 10.1016/0002-9343(74)90815-8. [DOI] [PubMed] [Google Scholar]
  12. Elias E. G., Evans J. T. Mithramycin in the treatment of Paget's disease of bone. J Bone Joint Surg Am. 1972 Dec;54(8):1730–1736. [PubMed] [Google Scholar]
  13. Fotino M., Haymovits A., Falk C. T. Evidence for linkage between HLA and Paget's disease. Transplant Proc. 1977 Dec;9(4):1867–1868. [PubMed] [Google Scholar]
  14. Francis M. D., Russell R. G., Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. 1969 Sep 19;165(3899):1264–1266. doi: 10.1126/science.165.3899.1264. [DOI] [PubMed] [Google Scholar]
  15. Frijlink W. B., Bijvoet O. L., te Velde J., Heynen G. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). Lancet. 1979 Apr 14;1(8120):799–803. doi: 10.1016/s0140-6736(79)91318-7. [DOI] [PubMed] [Google Scholar]
  16. Greenberg P. B., Doyle F. H., Fisher M. T., Hillyard C. J., Joplin G. F., Pennock J., MacIntyre I. Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes. Am J Med. 1974 Jun;56(6):867–870. doi: 10.1016/0002-9343(74)90816-x. [DOI] [PubMed] [Google Scholar]
  17. Guncaga J., Lauffenburger T., Lentner C., Dambacher M. A., Haas H. G., Fleisch H., Olah A. J. Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study. Horm Metab Res. 1974 Jan;6(1):62–69. [PubMed] [Google Scholar]
  18. Haddad J. G., Jr, Caldwell J. G. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins. J Clin Invest. 1972 Dec;51(12):3133–3141. doi: 10.1172/JCI107140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hamilton C. R., Jr Effects of synthetic salmon calcitonin in patients with Paget's disease of bone. Am J Med. 1974 Mar;56(3):315–322. doi: 10.1016/0002-9343(74)90613-5. [DOI] [PubMed] [Google Scholar]
  20. Hosking D. J., Bijvoet O. L., van Aken J., Will E. J. Paget's bone disease treated with diphosphonate and calcitonin. Lancet. 1976 Mar 20;1(7960):615–617. doi: 10.1016/s0140-6736(76)90420-7. [DOI] [PubMed] [Google Scholar]
  21. Jacobs T. P., Michelsen J., Polay J. S., D'Adamo A. C., Canfield R. E. Giant cell tumor in Paget's disease of bone: familial and geographic clustering. Cancer. 1979 Aug;44(2):742–747. doi: 10.1002/1097-0142(197908)44:2<742::aid-cncr2820440247>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  22. Kanis J. A., Horn D. B., Scott R. D., Strong J. A. Treatment of Paget's disease of bone with synthetic salmon calcitonin. Br Med J. 1974 Sep 21;3(5933):727–731. doi: 10.1136/bmj.3.5933.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kennedy B. J. Metabolic and toxic effects of mithramycin during tumor therapy. Am J Med. 1970 Oct;49(4):494–503. doi: 10.1016/s0002-9343(70)80044-4. [DOI] [PubMed] [Google Scholar]
  24. Khairi M. R., Johnston C. C., Jr, Altman R. D., Wellman H. N., Serafini A. N., Sankey R. R. Treatment of Paget disease of bone (osteitis deformans). Results of a one-year study with sodium etidronate. JAMA. 1974 Oct 28;230(4):562–567. [PubMed] [Google Scholar]
  25. Krane S. M., Muñoz A. J., Harris E. D., Jr Urinary polypeptides related to collagen synthesis. J Clin Invest. 1970 Apr;49(4):716–729. doi: 10.1172/JCI106284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levison V. The treatment of Paget's disease of bone by radiotherapy. Ann Phys Med. 1970 Feb;10(5):230–235. doi: 10.1093/rheumatology/x.5.230. [DOI] [PubMed] [Google Scholar]
  27. MAURICE P. F., LYNCH T. N., BASTOMSKY C. H., DULL T. A., AVIOLI L. V., HENNEMAN P. H. Metabolic evidence for suppression of Paget's disease of bone by aspirin. Trans Assoc Am Physicians. 1962;75:208–219. [PubMed] [Google Scholar]
  28. Meunier P. J., Chapuy M. C., Alexandre C., Bressot C., Edouard C., Vignon C., Mathieu L., Trechsel U. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone. Lancet. 1979 Sep 8;2(8141):489–492. doi: 10.1016/s0140-6736(79)91551-4. [DOI] [PubMed] [Google Scholar]
  29. Meunier P., Chapuy M. C., Courpron P., Vignon E., Edouard C., Bernard J. Effets cliniques, biologiques et histologiques de l'éthane-1-hydroxy 1, 1 diphosphonate (EDHP) dans la maladie de Paget. Rev Rhum Mal Osteoartic. 1975 Nov;42(11):699–705. [PubMed] [Google Scholar]
  30. Mills B. G., Singer F. R. Nuclear inclusions in Paget's disease of bone. Science. 1976 Oct 8;194(4261):201–202. doi: 10.1126/science.959849. [DOI] [PubMed] [Google Scholar]
  31. NAGANTDEDEUXCHAISNES C., KRANE S. M. PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS. Medicine (Baltimore) 1964 May;43:233–266. [PubMed] [Google Scholar]
  32. Naiken V. S. Did Beethoven have Paget's disease of bone? Ann Intern Med. 1971 Jun;74(6):995–999. doi: 10.7326/0003-4819-74-6-995. [DOI] [PubMed] [Google Scholar]
  33. Nisce L. Z., Geller W., D'Angio G. J. Experience with a new technique for "total node" irradiation--Hodgkin's disease. Br J Radiol. 1974 Feb;47(554):108–111. doi: 10.1259/0007-1285-47-554-108. [DOI] [PubMed] [Google Scholar]
  34. Perlia C. P., Gubisch N. J., Wolter J., Edelberg D., Dederick M. M., Taylor S. G., 3rd Mithramycin treatment of hypercalcemia. Cancer. 1970 Feb;25(2):389–394. doi: 10.1002/1097-0142(197002)25:2<389::aid-cncr2820250217>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  35. Reiner M., Jung A., Seiler A., Schenk R., Fleisch H. Le traitement de la maladie de Paget par les diphosphonates. Schweiz Med Wochenschr. 1975 Dec 13;105(50):1701–1703. [PubMed] [Google Scholar]
  36. Russell A. S., Lentle B. C. Mithramycin therapy in Paget's disease. Can Med Assoc J. 1974 Feb 16;110(4):397–400. [PMC free article] [PubMed] [Google Scholar]
  37. Russell R. G., Fleisch H. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects. Clin Orthop Relat Res. 1975 May;(108):241–263. doi: 10.1097/00003086-197505000-00038. [DOI] [PubMed] [Google Scholar]
  38. Ryan W. G. Paget's disease of bone. Annu Rev Med. 1977;28:143–152. doi: 10.1146/annurev.me.28.020177.001043. [DOI] [PubMed] [Google Scholar]
  39. Ryan W. G., Schwartz T. B., Northrop G. Experiences in the treatment of Paget's disease of bone with mithramycin. JAMA. 1970 Aug 17;213(7):1153–1157. [PubMed] [Google Scholar]
  40. Ryan W. G., Schwartz T. B., Northrop G. Treatment of Paget's disease with mithramycin: further experiences. Semin Drug Treat. 1972 Summer;2(1):57–64. [PubMed] [Google Scholar]
  41. Ryan W. G., Schwartz T. B., Perlia C. P. Effects of mithramycin on Paget's disease of bone. Ann Intern Med. 1969 Mar;70(3):549–557. doi: 10.7326/0003-4819-70-3-549. [DOI] [PubMed] [Google Scholar]
  42. Simon L., Blotman F., Seignalet J., Claustre J. Etiologie de la maladie osseuse de Paget. Rev Rhum Mal Osteoartic. 1975 Oct;42(10):535–544. [PubMed] [Google Scholar]
  43. Singer F. R. Human calcitonin treatment of Paget's disease of bone. Clin Orthop Relat Res. 1977;(127):86–93. [PubMed] [Google Scholar]
  44. Smith R., Russell R. G., Bishop M. Diphosphonates and Page's disease of bone. Lancet. 1971 May 8;1(7706):945–947. doi: 10.1016/s0140-6736(71)91447-4. [DOI] [PubMed] [Google Scholar]
  45. Woodhouse N. J., Fisher M. T., Sigurdsson G., Joplin G. F., MacIntyre I. Paget's disease in a 5-year-old: acute response to human calcitonin. Br Med J. 1972 Nov 4;4(5835):267–269. doi: 10.1136/bmj.4.5835.267. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES